Atos , a global leader of AI-powered digital transformation, today announces the appointment of Judith Stewart as Head of Healthcare & Life Sciences for Asia Pacific, reinforcing the company’s commitment to accelerating growth and innovation across the sector and helping organizations harness the potential of artificial intelligence, sovereign technologies and cybersecurity.
Judith brings more than 18 years of international healthcare leadership experience, with a strong track record delivering healthcare reforms and transformations for public and private sector organizations across Australia and the UK. Prior to joining Atos, she held Executive roles for several years within WA Health, most recently as Executive Director for Child and Adolescent Community Health Services in Perth, Western Australia.
In her new role, Judith will lead Atos’ Healthcare & Life Sciences business across Asia Pacific, with a focus on accelerating growth, strengthening customer relationships, fostering innovation and supporting clients as they navigate an increasingly complex technology landscape.
Daniele Principato, EVP and Head of International Markets at Atos, said: “Judith brings extensive healthcare leadership experience and a deep understanding of the challenges facing the sector. Her appointment strengthens our Healthcare & Life Sciences capabilities in Asia Pacific and our ability to help clients accelerate transformation while addressing critical priorities around AI, cybersecurity and digital sovereignty.”
Judith Stewart, Head of Healthcare & Life Sciences, Asia Pacific at Atos, said: “I am delighted to join Atos and look forward to working with our talented teams, customers and partners across Asia Pacific. Healthcare and Life Sciences organizations are navigating significant change, and technology and AI have an important role to play in helping them transform and innovate. I look forward to helping our clients unlock that potential and deliver meaningful outcomes for the communities they serve.”
The appointment reflects Atos’ continued investment in Asia Pacific and its commitment to supporting Healthcare & Life Sciences organizations as they harness advanced technologies to transform healthcare delivery, strengthen resilience and drive sustainable innovation.
